Is This Biotech Stock a Buy After Its Massive Rally?
This biotech has a powerful growth story, but one competitive threat could reshape the entire investment case before the payoff arrives.
Read the full articleYou might also wanna read
STAT+: Halfway into the year, biotech is booming
The biotech stock rally that began in April 2025 has not stopped, and if anything, has accelerated.
Jim Cramer Says Biotech is The Hottest Group in The Market Right Now
CNBC’s Jim Cramer pushed viewers away from the usual semiconductor and hyperscaler chatter. Instead, he highlighted a group he says has quie
Tech Stock Surge Fueled by AI Trade Resurgence
Technology stocks are surging, driven by a strong AI trade. Investors are focusing on AI-powered companies, signaling a positive outlook for
Big Tech's trillion-dollar AI bet faces investor skepticism over consumer demand
Technology companies are betting trillions of dollars that consumers will open their wallets for AI services. But what if Big Tech is wrong?
cbsnews.com·14d ago
China's biotech rise: A case study in multiple myeloma drug development
A drug for multiple myeloma should have been an early warning that China is racing ahead in biotech
writingruxandrabio.com·16d agoBiotech NRx to sell new shares to fund growth and operations
#NRXP NRx Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
Comments
Sign in to join the conversation.
No comments yet. Be the first.